Virpax Pharmaceuticals (VRPX)
NASDAQ:VRPX
US Market

Virpax Pharmaceuticals (VRPX) Financial Statements

90 Followers

Virpax Pharmaceuticals Financial Overview

Virpax Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-14.418; its P/E ratio is -0.09; Virpax Pharmaceuticals is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-1.53. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -6.12M$ -3.11M$ -1.52M$ -2.99M$ -7.64M
EBITDA$ -6.12M$ -3.11M$ -1.52M$ -2.99M$ -7.64M
Net Income Common Stockholders$ -5.99M$ -3.11M$ 1.78M$ -2.99M$ -7.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 16.99M$ 19.00M$ 20.56M
Total Assets$ 13.04M$ 15.95M$ 18.49M$ 19.67M$ 23.64M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 0.00$ -16.99M$ -19.00M$ -20.56M
Total Liabilities$ 6.53M$ 3.65M$ 3.29M$ 3.09M$ 4.21M
Stockholders Equity$ 6.51M$ 12.30M$ 15.20M$ 16.58M$ 19.43M
Cash Flow-
Free Cash Flow$ -2.65M$ -2.18M$ -2.01M$ -1.57M$ -5.50M
Operating Cash Flow$ -2.65M$ -2.18M$ -2.01M$ -1.57M$ -5.50M
Investing Cash Flow-----
Financing Cash Flow----$ 0.00
Currency in USD

Virpax Pharmaceuticals Earnings and Revenue History

Virpax Pharmaceuticals Debt to Assets

Virpax Pharmaceuticals Cash Flow

Virpax Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis